Upon cisplatin treatment, KD of either the DDB2 or XPC gene increased DNA damage and induced apoptosis in KRAS-mutant NSCLC cells, thereby sensitizing these cells to cisplatin treatment. This evidence concerns the gene KRAS and non-small cell lung carcinoma.